Cargando…

Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease

Mild cognitive impairment (MCI) is a syndrome which, depending on various neurobiological, psychological and social factors, carries a high risk of developing into dementia. As far as diagnostic uncertainty and the heterogeneous underlying pathophysiological mechanisms are concerned, only limited th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karakaya, Tarik, Fußer, Fabian, Schröder, Johannes, Pantel, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580783/ https://www.ncbi.nlm.nih.gov/pubmed/23814542 http://dx.doi.org/10.2174/157015913804999487

Ejemplares similares

Investigating the Association Between Polygenic Risk Scores for Alzheimer’s Disease With Cognitive Performance and Intrinsic Functional Connectivity in Healthy Adults
por: Ibnidris, Aliaa, et al.
Publicado: (2022)

Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease
por: Frank, Lori, et al.
Publicado: (2011)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Anosognosia in Mild Cognitive Impairment: Lack of Awareness of Memory Difficulties Characterizes Prodromal Alzheimer's Disease
por: Bastin, Christine, et al.
Publicado: (2021)

Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients
por: Alves, Gilberto Sousa, et al.
Publicado: (2012)

Neural Correlates of Autobiographical Memory: Evidence From a Positron Emission Tomography Study in Patients With Mild Cognitive Impairment and Alzheimer's Disease
por: Frankenberg, Claudia, et al.
Publicado: (2021)

Correction: Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients
por: Alves, Gilberto Sousa, et al.
Publicado: (2013)

Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
por: Watanabe, Hiroyuki, et al.
Publicado: (2023)

Neurological Soft Signs in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease – The Impact of Cognitive Decline and Cognitive Reserve
por: Urbanowitsch, Nadja, et al.
Publicado: (2015)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy Bodies
por: Hansen, Niels, et al.
Publicado: (2023)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Mild behavioral impairment: A prodromal stage of dementia
por: Taragano, Fernando E., et al.
Publicado: (2008)

Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease
por: Nielsen, Rune B., et al.
Publicado: (2020)

Characterizing mild cognitive impairment in prodromal Parkinson’s disease: A community‐based study in China
por: Pan, Chenxi, et al.
Publicado: (2021)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Pharmacological and non‐pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review
por: Blackman, Jonathan, et al.
Publicado: (2020)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

The Two-Step Strategy Could Be Inadequate and Counteracting to Diagnose Prodromal Dementia or Mild Cognitive Impairment
por: Abbate, Carlo, et al.
Publicado: (2020)

Bilingualism as a Contributor to Cognitive Reserve? Evidence from Cerebral Glucose Metabolism in Mild Cognitive Impairment and Alzheimer’s Disease
por: Kowoll, Magdalena Eva, et al.
Publicado: (2016)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

Large-Scale Functional Networks, Cognition and Brain Structures Supporting Social Cognition and Theory of Mind Performance in Prodromal to Mild Alzheimer’s Disease
por: Valera-Bermejo, Jose Manuel, et al.
Publicado: (2021)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability
por: Curiel Cid, Rosie E., et al.
Publicado: (2019)

Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
por: Bertens, Daniela, et al.
Publicado: (2019)

Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
por: Wolfsgruber, Steffen, et al.
Publicado: (2014)

Inflammaging as a prodrome to Alzheimer's disease
por: Giunta, Brian, et al.
Publicado: (2008)

Amyloid imaging in prodromal Alzheimer's disease
por: Ossenkoppele, Rik, et al.
Publicado: (2011)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Time Perception in Prodromal Alzheimer's Dementia and in Prodromal Dementia With Lewy Bodies
por: Pai, Ming-Chyi, et al.
Publicado: (2021)

Is pharmacological intervention necessary in prodromal schizophrenia?
por: Zhao, Jingping, et al.
Publicado: (2012)

To Explore the Predictive Power of Visuomotor Network Dysfunctions in Mild Cognitive Impairment and Alzheimer’s Disease
por: Staal, Justine, et al.
Publicado: (2021)

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
por: Teng, Edmond, et al.
Publicado: (2022)

Memory Outcome in Prodromal and Mild Dementia with Lewy Bodies and Alzheimer’s Disease: A Longitudinal Study
por: Querry, Manon, et al.
Publicado: (2023)

Progression from Prodromal Alzheimer’s Disease to Mild Alzheimer’s Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions
por: Voss, Tiffini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1ctjsb0duk59hiopldsaalq99